sounds like everything is as i've witnessed just trading VRSEF....i believe it's the same exact share as a VRS just a name thing. all stocks V3T, VRS, and VRSEF are all the same unit with only a name and market location being different.....my understanding.
also, i don't believe the U.S. OTC!Qx is on a halt system for announcements and thus it continues to trade in VRSEF even when the market halts by canadian securities legality.
at any rate, i still believe the US is mostly in the dark as to the capability of VRSEF due to lack of awareness of the 200+ ninety+% accuracy lesion study results. people here probably are still in the "too good to be true" school of thought with respect to verisante. sort of like when Doctors first started using devices to monitor oxygen aka "oximeters" 60ish years ago people then probably thought that was snake oil too!
oh well....i expect sales figures any day now with expense projections and i'm thinking 4th Q results + the 22nd of January's presentation by the inventors of Aura's 1000ish lesion study to be tantalizing for the market. also who knows if there will be placement aka IPO of Verisante to the Nasdaq at some point in the near future and whatever that will do to SP VRS/VRSEF/V3T......nevertheless.....this is all just idle thinking....
back to our matter i do feel that trading doesn't halt in the US otcQx market for announcements which may affect share prices by the corporation for what it's worth. also, the few cents of share price difference are likely just day-to-day currency fluctuations with the home country being the price basis.......
Cheers! long weekend here in the states!
